bosentan anhydrous has been researched along with Hyperoxia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bir, F; Enli, Y; Ergin, H; Özdemir, ÖM; Şahin, B; Taban, Ö | 1 |
| Caldwell, E; de Frutos, S; Gonzalez Bosc, LV; Kanagy, NL; Nitta, CH; Walker, MK; Wang, J; Wang, W | 1 |
| Bejjani, G; Biarent, D; Hubloue, I; Jespers, P; Leeman, M; Mélot, C; Naeije, R | 1 |
3 other study(ies) available for bosentan anhydrous and Hyperoxia
| Article | Year |
|---|---|
The effects of bosentan on hyperoxia-induced lung injury in neonatal rats.
Topics: Actins; Animals; Animals, Newborn; Biomarkers; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Hyperoxia; Immunohistochemistry; Injections, Intraperitoneal; Lung; Lung Injury; Rats; Rats, Wistar; Treatment Outcome | 2019 |
NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Animals; Aorta, Thoracic; Bosentan; Dioxoles; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Genes, Reporter; Hemodynamics; Hyperoxia; Hypertension; Male; Mesenteric Arteries; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, Transgenic; NFATC Transcription Factors; Promoter Regions, Genetic; Protein Kinase Inhibitors; Receptor, Endothelin A; rho-Associated Kinases; Sulfonamides; Time Factors | 2010 |
Role of endothelins and nitric oxide in the pulmonary circulation of perinatal lambs during hyperoxia and hypoxia.
Topics: Animals; Animals, Newborn; Blood Pressure; Bosentan; Constriction, Pathologic; Dilatation, Pathologic; Endothelin Receptor Antagonists; Endothelins; Hyperoxia; Hypoxia; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Pulmonary Artery; Pulmonary Circulation; Sheep, Domestic; Sulfonamides; Vascular Resistance | 2006 |